about
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysisHarmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR projectIncreased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.How can the quality of medical data in pharmacovigilance, pharmacoepidemiology and clinical studies be guaranteed?Rituximab therapy for childhood Evans syndrome.Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA.Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial.Benzodiazepine use and risk of dementia: prospective population based study.Identifying atrial fibrillation in outpatients initiating oral anticoagulants based on medico-administrative data: results from the French national healthcare databases.Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project.Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.Case series in drug safety: a review to determine characteristics and quality.Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials.Stroke risk and NSAIDs: a systematic review of observational studies.Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study.The Benzodiazepine-Dementia Disorders Link: Current State of Knowledge.Road traffic crash risk associated with prescription of hydroxyzine and other sedating H1-antihistamines: A responsibility and case-crossover study.The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.Methods for safety signal detection in healthcare databases: a literature review.Vaccine Case-Population: A New Method for Vaccine Safety Surveillance.Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome.Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactions.Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users.A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases.Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study.A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding.Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting.A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases.Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France.A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France.Prevalence of cholinesterase inhibitors in subjects with dementia in Europe.Can contrast dobutamine stress echocardiography be performed with standardized imaging settings for everybody?Proteinuria following a switch from calcineurin inhibitors to sirolimus.Why are benzodiazepines not yet controlled substances?Validity of chronic drug exposure presumed from repeated patient interviews varied according to drug class.Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance Database.Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients.
P50
Q28275281-DE737B2A-2251-4AB2-A68C-1F63BA12AE28Q28709512-92F202E9-4CEE-4735-8A97-F06E9C00A87BQ30352315-7C8F514D-94DC-4824-9831-133AF3020BCAQ30663640-01D3059A-C4CF-4557-B93E-FC12381FED6EQ33377657-E1D9A44E-FEA6-4D93-B6BB-2B9FA28DE6B1Q33439923-13540877-F226-4C64-98F8-A29B8EA422CAQ33503787-3701117C-3068-4B04-AE74-590E32187EBBQ34413209-7E8AF47D-F301-47F0-936A-0AB409AB5FD7Q34643603-132FECD6-9526-453C-A4DD-355424369D40Q36308658-6F6C8146-3895-437D-A69A-EEB214F29234Q36771133-ED0BABB3-DFE1-406A-A594-FE32070B310BQ37731873-7864D90C-CA2B-4367-AD01-4266C681D432Q37809529-06C8C0E9-456B-43DB-B792-376C7BC70E87Q37862577-50F6850C-61CD-4486-A770-F672F37AF1B8Q37942486-74AE2E76-9824-411E-9CFE-5626E4386AC7Q38655951-CD5C98FF-1DBB-49DE-AF2F-875BCC2B0AF7Q38682567-1C450F82-5AAB-4D38-BCF6-8F6C6260E5C7Q38732166-EEAB5AAE-84B9-454A-A24A-8E55B2743339Q38764020-992AF63A-5BA7-44E3-A352-AAF49EEC3A6BQ38793916-253367A6-6A73-4034-9677-3849922D66CBQ38804897-2ACC130E-2CB4-4597-8110-00BD00F1597EQ38998154-750075FB-388A-4347-88C1-DA27127B935FQ39822169-1F2D3D2F-8A0C-4900-BB5B-E790AD99AB52Q39882062-16780F2E-757E-4719-B71D-57F32F47EE99Q40160191-BD4E4124-EF44-44CC-BDFA-404C1B2A58DCQ40561790-EECC2F7A-D294-4EE9-9FE4-B8A9B1D66A0FQ40944247-E57E5A9D-8AE9-42D6-BB65-764B6BA866E9Q43210417-91FB6941-48E4-4D40-8B4A-170B2FFDB186Q44018531-702F07CE-28CB-43C7-BAA2-B25AF94F254DQ44428648-E8E5B1C4-B16B-4B87-931F-1905B0CCF6F8Q44771754-D032AB17-63FA-4A4F-8ED1-C017FE035265Q46200243-C0A6D7BC-A1D5-4259-8C51-E7BB62574596Q46571021-82654305-341A-4345-83CA-3E8659AB19D4Q46794766-8BF304F2-D713-43F9-9298-DE80A0560F5AQ46825307-A2AA0C1F-FC3C-44F8-9736-66DEB0B5DCA7Q46989004-13E269DD-7429-46FD-AF26-EDF2B3006349Q47358924-AEC124EB-C4B4-40D1-9C5B-76D6E3198CA8Q47746831-BA32E3AD-2B8E-4D80-9F09-58964B688395Q47803775-582F9DF6-5D2E-4AA7-AAC3-27C4780699A8Q48135712-FBAEFB49-8552-4C2C-AB77-7CEC3928E7CB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antoine Pariente
@ast
Antoine Pariente
@en
Antoine Pariente
@es
Antoine Pariente
@nl
Antoine Pariente
@sl
type
label
Antoine Pariente
@ast
Antoine Pariente
@en
Antoine Pariente
@es
Antoine Pariente
@nl
Antoine Pariente
@sl
prefLabel
Antoine Pariente
@ast
Antoine Pariente
@en
Antoine Pariente
@es
Antoine Pariente
@nl
Antoine Pariente
@sl
P106
P1153
23390155100
P21
P2456
P31
P496
0000-0002-7873-5483